UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 18, 2017 (July 12, 2017)

 

ICTV BRANDS INC.
(Exact name of registrant as specified in its charter)

 

Nevada   000-49638   76-0621102
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

 

489 Devon Park Drive, Suite 306

Wayne, PA 19087

 
  (Address of principal executive offices)  

 

  484-598-2300  
  (Registrant’s telephone number, including area code)  

 

Not Applicable
(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  [  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  [  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 
 

 

Item 1.01 Entry Into A Material Definitive Agreement.

 

Termination and Release Agreement

 

On July 12, 2017, ICTV Brands Inc. (the “Company”), ICTV Holdings, Inc. (the “ICTV Holdings”), PhotoMedex, Inc. (“PHMD”), Radiancy, Inc. (“Radiancy”), PhotoTherapeutics Ltd. (“PHMD UK”), and Radiancy (Israel) Limited (“Radiancy Israel” and, together with PHMD, Radiancy, and PHMD UK, the “Sellers” and each, a “Seller”) entered into a Termination and Release Agreement (“Release Agreement”). The Company, ICTV Holdings and the Sellers are referred to herein individually as a “Party” and collectively as the “Parties.”

 

Under the terms of the Release Agreement, the Asset Purchase Agreement, dated October 4, 2016, as amended by the First Amendment to the Asset Purchase Agreement, dated January 23, 2017 (as so amended, the “Purchase Agreement”), is terminated and of no further force and effect, except for certain surviving rights, obligations and covenants described in the Release Agreement. Pursuant to the Release Agreement, each of the Company and ICTV Holdings, on the one hand, and the Sellers on the other hand, fully release, forever discharge and covenant not to sue any other Party, from and with respect to any and all past and present claims arising out of, based upon or relating to the Purchase Agreement (other than the surviving covenants described in the Release Agreement) or the transactions contemplated thereby.

 

Pursuant to the terms of the Release Agreement, the Company shall pay to PHMD, within 3 business days of the date of the Release Agreement, $2,000,000 in cash and in immediately available funds (the “Payment”). Subject to this Payment, neither the Company nor ICTV Holdings shall have any further royalty or other payment obligations under the Purchase Agreement.

 

The foregoing summary of the terms and conditions of the Release Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Release Agreement, which is attached hereto as Exhibit 10.1, and is incorporated herein by reference.

 

Bill of Sale

 

As partial consideration for the releases provided by ICTV Holdings to the Sellers pursuant to the Release Agreement and in accordance with the terms therein, on July 12, 2017, the Sellers and ICTV Holdings entered into a Bill of Sale and Assignment (“Bill of Sale”), which provides that each Seller sell, assign, transfer, convey and deliver to ICTV Holdings, and ICTV Holdings purchase and accept from each Seller, all of the right, title and interest, legal or equitable, of each such Seller in and to a deposit in the amount of $210,000 held by Sigmatron International, Inc. (“Sigmatron”), pursuant to an arrangement between one or more of the Sellers and Sigmatron.

 

The foregoing summary of the terms and conditions of the Bill of Sale does not purport to be complete and is qualified in its entirety by reference to the full text of the Bill of Sale, which is attached hereto as Exhibit 10.2, and is incorporated herein by reference.

 

Secured Promissory Note

 

On July 15, 2017, to secure the Payment, the Company issued a 30-month secured promissory note (the “Note”), to LeoGroup Private Investment Access, LLC (the “Holder”) in the principal amount of $2,000,000. The Note provides that the Company shall make monthly payments of $100,000 to the Holder for 30 months. The Note is secured by a first priority security interest in all the assets of Company, except the Company’s accounts receivable.

 

 
 

 

The Note contains customary covenants of the Company and customary events of default. Subject to the terms and conditions of the Note, so long as any event of default, as described in the Note, is continuing, without cure, for a period of five (5) business days after written notice from the Holder to the Company or a longer period if set forth in in the notice from Holder or if agreed to by the parties, all obligations of the Company under the Note shall be immediately due and payable, and the Holder may exercise any other remedies available at law or in equity.

 

The issuance of the Note was made in reliance upon an exemption from registration provided under Section 4(a)(2) of the Securities Act.

 

The foregoing summary of the terms and conditions of the Note does not purport to be complete and is qualified in its entirety by reference to the full text of the Note, which is attached hereto as Exhibit 4.1 and is incorporated herein by reference.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation of an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth under Item 1.01 regarding the Note is incorporated by reference into this Item 2.03.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Unless otherwise indicated, the following exhibits are filed herewith:

 

Exhibit No.   Description of Exhibit
     
4.1   Promissory Note, dated July 15, 2017, issued by ICTV Brands Inc. in favor of LeoGroup Private Investment Access, LLC in the principal amount of $2,000,000
     
10.1   Termination and Release Agreement, dated July 12, 2017, by and among ICTV Brands Inc., ICTV Holdings, Inc., PhotoMedex, Inc., Radiancy, Inc., PhotoTherapeutics Ltd., and Radiancy (Israel) Limited
     
10.2   Bill of Sale, dated July 12, 2017, by and among Photomedex, Inc., Radiancy, Inc., PhotoTherapeutics Ltd., Radiancy (Israel) Limited and ICTV Holdings, Inc.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ICTV BRANDS INC.
     
Date: July 18, 2017 By: /s/ Richard Ransom
  Name: Richard Ransom
  Title: President

 

 
 

 

EXHIBIT INDEX

 

Unless otherwise indicated, the following exhibits are filed herewith:

 

Exhibit No.   Description of Exhibit
     
4.1   Promissory Note, dated July 15, 2017, issued by ICTV Brands Inc. in favor of LeoGroup Private Investment Access, LLC in the principal amount of $2,000,000
     
10.1   Termination and Release Agreement, dated July 12, 2017, by and among ICTV Brands Inc., ICTV Holdings, Inc., PhotoMedex, Inc., Radiancy, Inc., PhotoTherapeutics Ltd., and Radiancy (Israel) Limited
     
10.2   Bill of Sale, dated July 12, 2017, by and among Photomedex, Inc., Radiancy, Inc., PhotoTherapeutics Ltd., Radiancy (Israel) Limited and ICTV Holdings, Inc.

 

 
 

 

 

 

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS PURSUANT TO SEC RULE 144 OR UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT AND THE SECURITIES LAWS OF ANY STATE COVERING SUCH SECURITIES OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE 1933 ACT AND THE SECURITIES LAWS OF ANY STATE.

 

PROMISSORY NOTE

30-MONTH TERM

$100,000.00 MONTHLY PAYMENTS

 

$2,000,000.00 July 15, 2017

 

FOR VALUE RECEIVED, the undersigned, ICTV BRANDS, INC. (the “Maker”) promises to pay to the order of LEOGROUP PRIVATE INVESTMENT ACCESS, LLC (the “ Holder ”), and their assigns, the maximum principal amount of Two Million and 00/100 DOLLARS ($2,000,000.00) by January 15, 2020 (the “ Maturity Date ”).

 

To secure the payment or performance, as the case may be, in full of the obligations under this Note, Maker has granted a first priority security interest to the Holder in ALL assets of the Maker except Maker’s accounts receivables. Also, Maker hereby pledges all equity of the Maker to Holder. Maker further grants Holder the right to make any and all UCC filings necessary to properly perfect the security interest granted herein.

 

Section 1. Monthly Payments of $100,000.00 for 30-Month Term

 

A. Generally . Maker promises to pay $100,000.00 each month pursuant to the “ Payment Schedule ” (see attached Exhibit A) which consists of both principal (“Principal”) and interest (“ Interest ”) payable each month for a 30-Month Term through the Maturity Date. All payments hereunder shall be paid on or before the dates indicated in the Payment Schedule and, if any such date shall not be a Business Day (as defined below), on the next succeeding Business Day to occur after such date (each date upon which principal and interest shall be so payable, a “ Payment Date ”). In addition, in the event of any prepayment of principal of this Note, such prepayment shall be accompanied by the interest accrued on the amount so prepaid. The term “ Business Day ” shall mean any day other than a Saturday, Sunday or other day on which commercial banks are authorized or required by law or executive order to close.

 

1  
 

 

B. Default Rate . Notwithstanding the foregoing provisions of this Section 1, but subject to applicable law, (i) any overdue principal of this Note if the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties, and (ii) any overdue accrued interest under this Note if the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties, which Maker shall have failed to pay on or prior to that date which is thirty (30) Business Days after the same is due and payable, each shall bear interest, payable on demand in immediately available funds, for each day from the date payment thereof was due through the date of actual payment, the effective interest rate will double (the “Default Rate”). Once the payment is made on any amounts subject to the Default Rate, the interest rate returns to the standard interest rate pursuant to the Payment Schedule.

 

C. No Usurious Interest . In the event that any interest rate(s) provided for in this Section 1 shall be determined to be unlawful, such interest rate(s) shall be computed at the highest rate permitted by applicable law. Any payment by the Maker of any interest amount in excess of that permitted by law shall be considered a mistake, with the excess being applied to the principal amount of this Note without prepayment premium or penalty; if no such principal amount is outstanding, such excess shall be returned to the Maker.

 

Section 2. Conversion Rights . There are no conversion rights attached to this Note.

 

Section 3. Repayment of Principal Amount . The principal amount of this Note (together with all accrued and unpaid interest, if any) shall be paid pursuant to the Payment Schedule such that the entire Note shall be repaid by the Maturity Date.

 

Section 4. Prepayment . This Note may not be prepaid, in whole or in part, at any time and from time to time, unless expressly agreed to in writing by the Holder.

 

Section 5. Forms of Payment . The payment or prepayment of the principal amount under this Note shall be payable in lawful money of the United States of America by check or by wire transfer to an account specified in writing by the Holder. Any payment under this Note shall be applied pursuant to the Payment Schedule. If any payments are made that differ from the Payment Schedule, such payments shall first be applied to sums due under this Note other than principal and interest, second to accrued interest (limited to accrued interest on the amount prepaid in the case of any prepayment of principal hereunder) and third to any principal amount outstanding under this Note.

 

Section 6. Events of Default . The occurrence and continuation for any reason whatsoever of any of the following events shall constitute an “ Event of Default ”:

 

  (a) Failure by the Maker to observe, perform or comply with any covenant or condition and the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or by written agreement of the parties;
     
  (b) The Maker shall fail to make payment of any principal on this Note when the same shall become due and payable and the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties;

 

2  
 

 

  (c) The Maker shall fail to make payment of any accrued and unpaid interest under this Note within ten (10) business days after the same shall have become due and payable if the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties,; or the Maker shall fail to make any payment of any fees due and payable hereunder within ten (10) business days after written demand therefor from Holder if the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties;
     
  (d) The Maker shall (i) fail to keep in full force and effect its existence as a limited liability company, (ii) apply for or consent to the appointment of a receiver, trustee, custodian or liquidator of it or any of its property, (iii) admit in writing its inability to pay its debts as they mature, (iv) make a general assignment for the benefit of creditors, (v) be adjudicated a bankrupt or insolvent or be the subject of an order for relief under Title 11 of the United States Code or (vi) file a voluntary petition in bankruptcy, or a petition or an answer seeking reorganization or an arrangement with creditors or to take advantage of any bankruptcy, reorganization, insolvency, readjustment of debt, dissolution or liquidation law or statute, or an answer admitting the material allegations of a petition filed against it in any proceeding under any such law or corporate action shall be taken for the purpose of effecting any of the foregoing;
     
  (e) There shall be filed against Maker an involuntary petition seeking reorganization of the Maker or the appointment of a receiver, trustee, custodian or liquidator of the Maker, or a substantial part of Maker’s assets, or an involuntary petition under any bankruptcy, reorganization or insolvency law of any jurisdiction, whether now or hereafter in effect and such involuntary petition shall not have been dismissed within ninety (90) days thereof.

 

Section 7. Rights upon Event of Default . If an Event of Default described in Section 6 has occurred and is continuing and if the same shall not be cured within five (5) business days after written notice from Holder to Maker or a longer period if set forth in the notice from Holder or a longer period if agreed to by the parties,, the Holder, at their option, may declare the aggregate principal amount of this Note, together with all accrued and unpaid interest thereon, immediately due and payable (except in the case of an Event of Default under paragraphs (d) or (e) of Section 6, in which event the aggregate principal amount of this Note, together with all accrued and unpaid interest thereon, shall automatically become due and payable).

 

3  
 

 

Section 8. Suits for Enforcement .

 

A. Upon the occurrence of an Event of Default by Maker, the Holder of this Note may proceed to protect and enforce his rights hereunder by suit in equity, action at law or by other appropriate proceeding, whether for the specific performance of any covenant or agreement contained in the this Note or in aid of the exercise of any power granted in this Note, or may proceed to enforce the payment of this Note, or to enforce any other legal or equitable right of the Holder of this Note.

 

B. If it is determined by a court of competent jurisdiction that Maker has breached this Note and after all avenues of appeal on such decision have been exhausted by Maker, Maker agrees to pay the Holder on demand all costs of collection and enforcement of this Note and the Pledge Agreement, including, without limitation, reasonable attorney’s fees and expenses and all court costs.

 

Section 9. Transferability . Holder shall be entitled to assign, transfer, hypothecate or otherwise convey this Note and its related rights to any Person without the consent of the Maker.

 

Section 10. Information Rights . The Maker agrees to provide Holder, at Holder’s request, financial information on a monthly basis no later than five (5) business days after the end of any calendar month.

 

Section 11. Miscellaneous .

 

A. Unconditional Obligation; Waivers . Maker hereby waives presentment and demand for payment, notice of non-payment, notice of dishonor, protest, notice of protest, bringing of suit and diligence in taking any action to collect any amount called for under this Note, and shall be directly and primarily liable for the payment of all amounts owing and to be owing hereon, regardless of and without any notice, diligence, act or omission with respect to the collection of any amount called for hereunder. No waiver of any provision of this Note made by agreement of the Holder and any other person shall constitute a waiver of any other terms hereof, or otherwise release or discharge the liability of the Maker under this Note. No failure to exercise and no delay in exercising, on the part of the Holder, any right, power or privilege under this Note shall operate as a waiver thereof nor shall partial exercise of any right, power or privilege. The rights and remedies herein provided are cumulative and are not exclusive of any rights or remedies provided by law.

 

B. Notices and Addresses . Any notice, demand, request, waiver, or other communication under this Note shall be in writing and shall be deemed to have been duly given on the date of service, if personally served or sent by facsimile; on the business day after notice is delivered to a courier or mailed by express mail, if sent by courier delivery service or express mail for next day delivery; and on the third day after mailing, if mailed to the party to whom notice is to be given, by first class mail, registered, return receipt requested, postage prepaid and addressed as follows:

 

To Maker:

LeoGroup Private Investment Access, LLC

c/o Matthew J. Allain

100 Wood Avenue South, #209

Iselin, NJ 08830

 

To Holder:

ICTV Brands, Inc.

489 Devon Park Drive, Suite #306

Wayne, PA 19087

 

4  
 

 

C. Severability; Binding Effect . Any provision of this Note which is invalid or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Note or affecting the validity or unenforceability of any of the terms and provisions of this Note in any other jurisdiction. This Note shall be binding upon and inure to the benefit of the parties hereto and their successors and permitted assigns. Neither this Note nor any rights or obligations hereunder may be assigned by the Maker.

 

D. Governing Law . THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE, WITHOUT REFERENCE TO ITS CONFLICT OF LAW PROVISIONS AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. The Holder and the Maker agree that any and all disputes about or involving the interpretation, construction, performance or breach of this Note, shall be brought in the state or federal courts of Delaware and each agree to exclusive personal jurisdiction and venue in the state and federal courts of Delaware. Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Note. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.

 

E. Amendment . This Note can be amended, supplemented or changed, and any provision hereof can be waived, only by written instrument making specific reference to this Note signed by the Maker, in the case of an amendment, supplement, modification or waiver sought to be enforced against the Maker, or by the Holder, in the case of an amendment, supplement, modification or waiver sought to be enforced against the Holder.

 

F. Section Headings . Section headings herein have been inserted for reference only and shall not be deemed to limit or otherwise affect, in any matter, or be deemed to interpret in whole or in part any of the terms or provisions of this Note.

 

[Signature Page Follows]

 

5  
 

 

IN WITNESS WHEREOF, this Note has been executed and delivered as of the date specified above.

 

ICTV BRANDS, INC.  
     
By: /s/ Richard S. Ransom  
Name: Richard S. Ransom  
Title: President  

 

LEOGROUP PRIVATE INVESTMENT ACCESS, LLC  
     
By: /s/ Matthew J. Allain  
Name: Matthew J. Allain  
Title: Manager  

 

[Exhibit A Follows]

 

6  
 

 

EXHIBIT A

 

PAYMENT SCHEDULE

 

$100,000.00 Payment Each Month

 

#     Due Date   Beginning Balance     Interest     Principal     Ending Balance  
                               
1     August 15, 2017   $ 2,000,000.00     $ 56,892.72     $ 43,107.28     $ 1,956,892.72  
2     September 15, 2017   $ 1,956,892.72     $ 55,666.47     $ 44,333.53     $ 1,912,559.19  
3     October 15, 2017   $ 1,912,559.19     $ 54,405.34     $ 45,594.66     $ 1,866,964.53  
4     November 15, 2017   $ 1,866,964.53     $ 53,108.34     $ 46,891.66     $ 1,820,072.87  
5     December 15, 2017   $ 1,820,072.87     $ 51,774.45     $ 48,225.56     $ 1,771,847.31  
6     January 15, 2018   $ 1,771,847.31     $ 50,402.60     $ 49,597.40     $ 1,722,249.92  
7     February 15, 2018   $ 1,722,249.92     $ 48,991.74     $ 51,008.26     $ 1,671,241.66  
8     March 15, 2018   $ 1,671,241.66     $ 47,540.74     $ 52,459.26     $ 1,618,782.39  
9     April 15, 2018   $ 1,618,782.39     $ 46,048.46     $ 53,951.54     $ 1,564,830.86  
10     May 15, 2018   $ 1,564,830.86     $ 44,513.74     $ 55,486.26     $ 1,509,344.59  
11     June 15, 2018   $ 1,509,344.59     $ 42,935.36     $ 57,064.64     $ 1,452,279.95  
12     July 15, 2018   $ 1,452,279.95     $ 41,312.08     $ 58,687.92     $ 1,393,592.03  
13     August 15, 2018   $ 1,393,592.03     $ 39,642.62     $ 60,357.38     $ 1,333,234.64  
14     September 15, 2018   $ 1,333,234.64     $ 37,925.67     $ 62,074.33     $ 1,271,160.31  
15     October 15, 2018   $ 1,271,160.31     $ 36,159.88     $ 63,840.12     $ 1,207,320.19  
16     November 15, 2018   $ 1,207,320.19     $ 34,343.86     $ 65,656.14     $ 1,141,664.06  
17     December 15, 2018   $ 1,141,664.06     $ 32,476.18     $ 67,523.82     $ 1,074,140.24  
18     January 15, 2019   $ 1,074,140.24     $ 30,555.38     $ 69,444.62     $ 1,004,695.62  
19     February 15, 2019   $ 1,004,695.62     $ 28,579.93     $ 71,420.07     $ 933,275.55  
20     March 15, 2019   $ 933,275.55     $ 26,548.29     $ 73,451.71     $ 859,823.84  
21     April 15, 2019   $ 859,823.84     $ 24,458.86     $ 75,541.14     $ 784,282.69  
22     May 15, 2019   $ 784,282.69     $ 22,309.99     $ 77,690.01     $ 706,592.68  
23     June 15, 2019   $ 706,592.68     $ 20,099.99     $ 79,900.01     $ 626,692.67  
24     July 15, 2019   $ 626,692.67     $ 17,827.12     $ 82,172.88     $ 544,519.79  
25     August 15, 2019   $ 544,519.79     $ 15,489.61     $ 84,510.40     $ 460,009.40  
26     September 15, 2019   $ 460,009.40     $ 13,085.59     $ 86,914.41     $ 373,094.99  
27     October 15, 2019   $ 373,094.99     $ 10,613.19     $ 89,386.81     $ 283,708.18  
28     November 15, 2019   $ 283,708.18     $ 8,070.46     $ 91,929.54     $ 191,778.64  
29     December 15, 2019   $ 191,778.64     $ 5,455.40     $ 94,544.60     $ 97,234.05  
30     January 15, 2020   $ 97,234.05     $ 2,765.95     $ 97,234.05     $ 0.00  

 

7  
 

 

 

TERMINATION AND

RELEASE AGREEMENT

 

This Termination and Release Agreement ( the “ Agreement ”) is made and entered into as of July 12, 2017, by and among ICTV Brands Inc. , a Nevada corporation (“ Parent ”), ICTV Holdings, Inc. , a Nevada corporation (“ Purchaser ”), PhotoMedex, Inc. , a Nevada corporation (“ PHMD ”), Radiancy, Inc. , a Delaware corporation (“ Radiancy ”), PhotoTherapeutics Ltd ., a private limited company limited by shares, incorporated under the laws of England and Wales (“ PHMD UK ”), and Radiancy (Israel) Limited , a private corporation incorporated under the laws of the State of Israel (“ Radiancy Israel ” and, together with PHMD, Radiancy, and PHMD UK, the “ Sellers ” and each, a “ Seller ”). Parent, Purchaser and the Sellers are each sometimes referred to herein as a “ Party ” and, collectively, as the “ Parties .”

 

Recitals

 

A. The Parties have entered into that certain Asset Purchase Agreement, dated October 4, 2016, which was then amended on January 23, 2017 (as so amended, the “ Purchase Agreement ”). Capitalized terms used herein without definition shall have the meanings given to them in the Purchase Agreement.

 

B. On January 23, 2017, the parties consummated the transactions contemplated by the Purchase Agreement at the Closing, including the transfer of the Transferred Assets to the Purchaser.

 

C. Certain disputes have arisen between the Parties since the Closing regarding the treatment of various matters under the Purchase Agreements. The Parties desire to finally resolve all disputes among them in the manner set forth in this Agreement, terminate the Purchase Agreement, and release each other from all obligations under the Purchase Agreement other than those obligations described below as specifically surviving the termination of the Purchase Agreement.

 

Agreement

 

Now, Therefore , in consideration of the foregoing recitals and the mutual promises, representations, warranties, and covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:

 

1. Parent Payment. Within three (3) Business Days from the date hereof, Parent shall pay to PHMD Two Million Dollars ($2,000,000) in cash and in immediately available funds.

 

2. Sigmatron Assignment . Pursuant to PHMD’s existing arrangement with Sigmatron International, Inc. (“ Sigmatron ”), PHMD deposited a total of Two Hundred Ten Thousand Dollars ($210,000) (the “ Deposit ”) with Sigmatron. PHMD has demanded that Sigmatron return the Deposit, but Sigmatron has failed to do so. PHMD hereby assigns to Parent all of PHMD’s right, title and interests in and to the Deposit. To further assign the Deposit to Parent, PHMD shall, on the date hereof, execute and deliver to Parent a bill of sale and assignment in the form of Exhibit A to this Agreement. The Sellers jointly and severally represent and warrant to Parent and Purchaser that PHMD has good and marketable title to the Deposit free and clear of all Liens, except for Permitted Liens.

 

 
   

 

3. Termination of Agreement . Effective as of the date hereof, except for the Surviving Covenants described in Section 4 of this Agreement, the Purchase Agreement is terminated and of no further force and effect and none of the Parties will have any further rights or obligations under or pursuant to the Agreement; provided, however, that rights and obligations of the parties under the Purchase Agreement incurred at the Closing shall survive the termination of the Purchase Agreement, including, but in no way limited to, the transfer of the Transferred Assets to the Purchaser that occurred at the Closing and the entry into the Transaction Documents, including specifically and without limitation, the Transfer Documents, which remain in full force and effect. For the avoidance of doubt, subject to Parent making the payment described in Section 1 of this Agreement, neither Parent nor Purchaser shall have any further royalty or other payment obligations (or obligations to deliver any other consideration for the Transferred Assets) under the Purchase Agreement.

 

4. Covenants of the Parties . The following covenants contained in the Purchase Agreement (the “ Surviving Covenants ”) shall survive the termination of the Purchase Agreement and remain in full force and effect in accordance with their terms: Section 5.2 (Transaction Expenses; Transfer Taxes); Section 5.3 (Further Assurances); Section 5.6 (Non-Compete and Non-Solicitation); Section 5.7 (PhotoMedex and Radiancy Names); Section 5.8 (Notices and Consents); Section 5.14 (Payment of Excluded Liabilities) (provided that Parent specifically waives and releases its right to make any claim against the Sellers for products that were returned after the Closing relating to sales occurring prior to the Closing and such claim is released under Section 5 hereof); Article VIII (Tax Matters); Section 10.1 (Confidentiality); Section 10.5 (Mediation; Arbitration and Governing Law); and Section 10.7 (Notices).

 

5. Mutual Release; Disclaimer of Liability . Each of the Parent and the Purchaser on the one hand and each of the Sellers on the other hand, each on behalf of itself and each of its respective successors and past and present subsidiaries, Affiliates, assignees, officers, directors, employees, controlling persons, Representatives, agents, attorneys, auditors, stockholders, equity holders and advisors, and any family member, spouse, heir, trust, trustee, executor, estate, administrator, beneficiary, foundation, fiduciary, predecessors, successors and assigns of each of them (the “ Releasors ”), does, to the fullest extent permitted by law, hereby fully release, forever discharge and covenant not to sue any other Party, any of their respective successors and past and present subsidiaries, Affiliates, assignees, officers, directors, employees, controlling persons, Representatives, agents, attorneys, auditors, stockholders, equity holders and advisors, and any family member, spouse, heir, trust, trustee, executor, estate, administrator, beneficiary, foundation, fiduciary, predecessors, successors and assigns of each of them (collectively the “ Releasees ”), from and with respect to any and all past, present, direct, indirect, individual, class, representative and derivative liability, claims, rights, actions, causes of action, suits, liens, obligations, accounts, debts, losses, demands, judgments, remedies, agreements, promises, liabilities, covenants, controversies, costs, charges, damages, expenses and fees (including attorney’s, financial advisor’s or other fees) (“ Claims ”), howsoever arising, of every kind and nature, whether based on any law or right of action (including any claims under federal securities laws or state disclosure law or any claims that could be asserted derivatively on behalf of the Parties), known or unknown, asserted or that could have been asserted, matured or unmatured, contingent or fixed, liquidated or unliquidated, accrued or unaccrued, foreseen or unforeseen, apparent or not apparent, which Releasors, or any of them, ever had or now have or can have or shall or may hereafter have against the Releasees, or any of them, in connection with, arising out of, based upon or related to, directly or indirectly, the Purchase Agreement (other than the Surviving Covenants) or the transactions contemplated therein or thereby, including any breach, non-performance, action or failure to act under the Purchase Agreement, the events leading to the termination of the Purchase Agreement, any deliberations or negotiations in connection with the Purchase Agreement, the consideration to be received under the Purchase Agreement, including any royalties thereunder, and any SEC filings, public filings, periodic reports, press releases, proxy statements or other statements issued, made available or filed relating, directly or indirectly, to the Purchase Agreement or the transactions consummated at the Closing. The release contemplated by this Section 5 is intended to be as broad as permitted by law and is intended to, and does, extinguish all Claims of any kind whatsoever, whether in law or equity or otherwise, that are based on or relate to facts, conditions, actions or omissions (known or unknown) that have existed or occurred at any time to and including as of the date hereof. Each of the Releasors hereby expressly waives to the fullest extent permitted by law any rights it may have under any statute or common law principle under which a general release does not extend to claims which such Party does not know or suspect to exist in its favor at the time of executing the release. Nothing in this Section 5 shall (i) apply to any action by any Party to enforce the rights and obligations imposed pursuant to this Agreement, including under the Surviving Covenants, the Transaction Documents, including the Transfer Documents, or the Parent and/or the Purchaser’s rights in and to the Transferred Assets as conveyed to the Parent and/or the Purchaser at the Closing pursuant to the Purchase Agreement, or (ii) constitute a release by any Party for any Claim arising under this Agreement, the Transaction Documents, including the Transfer Documents, or the Parent and/or the Purchaser’s rights in and to the Transferred Assets as conveyed to the Parent and/or the Purchaser at the Closing pursuant to the Purchase Agreement.

 

 
   

 

6. Representations and Warranties . Each of the Parties represents and warrants that it has the requisite power to enter into this Agreement and to carry out its obligations hereunder and that the terms of this Agreement have been fully disclosed to its board of directors and that the requisite approvals have been obtained, prior to its execution. Each of the Parties represents and warrants to the other Parties that this Agreement has been duly executed and delivered and constitutes a valid and binding obligation enforceable in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

 

7. Integration Clause . This Agreement contains the entire agreement of the Parties and supersedes any and all prior, written or oral, agreements among them concerning the subject matter of this Agreement. There are no representations, agreements, arrangements or understandings, oral or written, among the Parties, relating to the subject matter of this Agreement that is not fully expressed herein.

 

8. Severability . If any one or more of the provisions of this Agreement should be ruled wholly or partly invalid or unenforceable by a court or other government body of competent jurisdiction, then; (i) the validity and enforceability of all provisions of this Agreement not ruled to be invalid or unenforceable shall be unaffected if the Parties mutually elect in writing to proceed as if such invalid or unenforceable term(s) had never been included in the Agreement; (ii) the effect of the ruling shall be limited to the jurisdiction of the court or other government body making the ruling; (iii) the provision(s) held wholly or partly invalid or unenforceable shall be deemed amended, and the court or other government body is authorized to reform the provision(s), to the minimum extent necessary to render them valid and enforceable in conformity with the Parties’ intent as manifested herein; and (iv) if the ruling and/or the controlling principle of law or equity leading to the ruling is subsequently overruled, modified, or amended by legislature, judicial, or administrative action, then the provision(s) in question as originally set forth in this Agreement shall be deemed valid and enforceable to the maximum extent permitted by the new controlling principle of law or equity.

 

9. No Waiver . The failure of any party to insist upon compliance with any of the provisions of this Agreement or the waiver thereof, in any instance, shall not be construed as a general waiver or relinquishment by such party of any other provision of this Agreement.

 

 
   

 

10. Mediation; Arbitration and Governing Law . In the event of a dispute between any of the Parties arising under or relating in any way whatsoever to this Agreement, the disputing Parties shall attempt to resolve it through good faith negotiation. If the dispute is not resolved through such negotiation, then the disputing Parties shall attempt to resolve it through mediation in the State of Pennsylvania, USA, with a neutral, third-party mediator mutually agreed upon by the disputing Parties. Unless otherwise agreed by the disputing Parties, the costs of mediation shall be shared equally. If the dispute is not resolved through mediation, then upon written demand by one of the disputing Parties it shall be referred to a mutually agreeable arbitrator. The arbitration process shall be conducted in accordance with the laws of the Commonwealth of Pennsylvania, except as modified herein. Venue for the arbitration hearing shall be the State of Pennsylvania, USA. All remedies, legal and equitable, available in court shall also be available in arbitration. The arbitrator’s decision shall be final and binding, and judgment may be entered thereon in a court of competent jurisdiction. This Agreement shall be interpreted and enforced in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflict of law principles thereof. In any dispute arising out of or relating in way whatsoever to this Agreement, including arbitration, the substantially prevailing Party shall be entitled to recover its costs and attorney fees from the other disputing Parties.

 

11. Amendment . This Agreement may not be amended except by an instrument in writing, executed by the Parties, and each of them.

 

12. No Reliance . Each of the Parties represents and warrants that, except for the representations and warranties specifically set forth in this Agreement, in executing this Agreement, it does not rely, and has not relied, on any representation or statement made by any other party to this Agreement, on any representation or statement made anyone acting on behalf of any party to this Agreement, or any representation or statement made by any other person.

 

13. Counterparts . This Agreement may be executed in multiple counterpart copies, each of which shall be considered an original and all of which constitute one and the same instrument binding on all the parties, notwithstanding that all parties are not signatories to the same counterpart.

 

14. Successors . Except as otherwise provided herein, this Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns.

 

[Signature page follows]

 

 
   

 

In Witness Whereof , the parties hereto have executed this Agreement as of the date first written above.

 

  PARENT:
   
  ICTV BRANDS INC.
     
  By: /s/ Richard Ransom
  Name:  Richard Ransom                          
  Title: President
     
  PURCHASER :
   
  ICTV Holdings, INC.
     
  By: /s/ Richard Ransom
  Name: Richard Ransom
  Title: President
     
  SELLERS :
     
  PhotoMedex, Inc.
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: Chief Executive Officer
     
  RADIANCY, Inc.
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: President
     
  PHOTOTHERAPEUTICS LTD.
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: Director
     
  RADIANCY (ISRAEL) LIMITED
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: Director

 

 
   

 

 

 

BILL OF SALE AND ASSIGNMENT

 

THIS BILL OF SALE AND ASSIGNMENT (this “ Bill of Sale ”) is made and entered into as of July 12, 2017, by and among PhotoMedex, Inc. , a Nevada corporation, Radiancy, Inc. , a Delaware corporation, PhotoTherapeutics Ltd. , a private limited company limited by shares incorporated under the laws of England and Wales, Radiancy (Israel) Limited , a private corporation incorporated under the laws of the State of Israel (each, a “ PHMD Party ”), and ICTV Holdings, Inc. , a Nevada corporation (“ ICTV ”). Capitalized terms used, but not otherwise defined, herein have the meanings ascribed to them in the Release Agreement (as defined below).

 

RECITALS

 

A. The PHMD Parties and ICTV have entered into Termination and Release Agreement, dated on or about the date hereof (the “ Release Agreement ”), whereby the Parties agreed to terminate that certain Asset Purchase Agreement among the Parties, dated January 23, 2017 (the “ Purchase Agreement ”) and release each other from certain liabilities arising under the Purchase Agreement among others.

 

B. As partial consideration for the releases provided by ICTV to the PHMD Parties as contained in the Release Agreement, the PHMD Parties are required to sell, assign, transfer, convey and deliver to ICTV a deposit in the amount of Two Hundred Ten Thousand Dollars ($210,000) held by Sigmatron International, Inc. (“ Sigmatron ”) pursuant to an arrangement between one or more of the PHMD Parties and Sigmatron.

 

C. The execution and delivery of this Bill of Sale is a condition concurrent to the transactions contemplated by the Release Agreement, which transactions are occurring on the date hereof.

 

AGREEMENT

 

NOW, THEREFORE, pursuant to and in accordance with the terms and provisions of the Purchase Agreement, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Transfer of Deposit . Each PHMD Party does hereby sell, assign, transfer and deliver to ICTV, and ICTV does hereby purchase and accept from such PHMD Party, all of the right, title and interest, legal or equitable, of each such PHMD Party in and to the Deposit.

 

2. Further Assurances . Each PHMD Party hereby covenants and agrees to execute and deliver, or cause to be executed and delivered, all such further acts, assignments, transfers, assurances, conveyances, notices, assumptions, releases and acquittances and such other instruments, and shall take such further actions, as may be reasonably necessary or appropriate to assure fully the transfer and conveyance of all of the Deposit intended to be transferred and conveyed to ICTV hereunder.

 

 
   

 

3. Power of Attorney . Each PHMD Party hereby constitutes and appoints ICTV, its successors and assigns, as such PHMD Party’s true and lawful attorney, with full power of substitution, in such PHMD Party’s name and stead, but on behalf and for the benefit of ICTV, its successors and assigns, to demand and receive any and all of the Deposit, and to execute and deliver receipts, releases and such other instruments or documents as ICTV may reasonably deem necessary or appropriate in connection with the demand and receipt of the same, and any part thereof, and from time to time to institute and prosecute in such PHMD Party’s name, or otherwise, for the benefit of ICTV, its successors and assigns, any and all proceedings at law, in equity or otherwise, which ICTV, its successors or assigns, may deem proper for the collection or reduction to possession of any of the Deposit or for the collection and enforcement of any claim or right of any kind hereby sold, conveyed, transferred and assigned, or intended so to be, and to do all acts and things in relating to the Deposit which ICTV, its successors or assigns shall deem desirable. Each PHMD Party hereby declares that the foregoing powers are coupled with an interest and are and shall be irrevocable by such PHMD Party or by its dissolution or in any manner or for any reason whatsoever.

 

4. Exclusivity . Nothing contained herein, express or implied, shall be construed, nor is intended, to confer upon any person, firm or entity other than ICTV, its successors and assigns, any remedy or claim under or by reason of this Bill of Sale or any term, covenant and condition thereof, and such terms, covenants and conditions shall be for the exclusive benefit of ICTV, its successors and assigns.

 

5. Amendments . No provision of this Bill of Sale may be amended, modified or waived except by written agreement duly executed by each of the Parties hereto.

 

6. Successors and Assigns . This Bill of Sale shall be binding upon and shall inure to the benefit of the parties and their respective personal representatives, heirs, successors and assigns.

 

7. Governing Law . This Bill of Sale shall be governed by and construed and enforced in accordance with the laws of the Commonwealth of Pennsylvania applicable to contracts made in that state, without giving effect to the conflict of laws principles thereof.

 

8. Counterparts; Delivery by Electronic Transmission . This Bill of Sale may be executed simultaneously in counterparts (including by means of facsimile or portable document format (pdf) signature pages), any one of which need not contain the signatures of more than one party hereto, but all such counterparts taken together shall constitute one and the same instrument. This Bill of Sale, to the extent signed and delivered by means of a facsimile machine or electronic transmission in portable document format (pdf), shall be treated in all manner and respects as an original thereof and shall be considered to have the same binding legal effects as if it were the original signed version thereof delivered in person. At the request of any party hereto, the other party shall re-execute original forms hereof and deliver them to the other parties. No party hereto shall raise the use of a facsimile machine or electronic transmission in portable document format (pdf) to deliver a signature or the fact that any signature or document was transmitted or communicated through the use of a facsimile machine or electronic transmission in portable document format (pdf) as a defense to the formation of a contract, and each such party forever waives any such defense.

 

2
   

 

IN WITNESS WHEREOF, this Bill of Sale and Assignment has been executed and delivered on the date first above written.

 

  PHMD PARTYS :
   
  PhotoMedex, Inc.
     
  By: /s/ Suneet Singal
  Name:  Suneet Singal
  Title: CEO
     
  Radiancy, Inc.
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: CEO
     
  PhotoTherapeutics Ltd.
     
  By: /s/ Suneet Singal
Name: Suneet Singal                        
  Title: Director
     
  Radiancy (Israel) Limited
     
  By: /s/ Suneet Singal
  Name: Suneet Singal
  Title: Director
     
  ICTV :
   
  ICTV Holdings, Inc.
     
  By: /s/ Richard Ransom
  Name: Richard Ransom
  Title: President